Save the date for this upcoming Southeast District Meeting! Meeting will begin at 7:00 pm and educational content at 7:30 pm

Register Today! 

Location: Virtual (Zoom)

Please note: Attendees must be sure to include their full names for attendance and certificate purposes. It is not recommended to share computers while attending a continuing education course as certificates will only be sent to the individual whose full name is shown on the participant list.

Speaker: Patricia Crane, PT, DPT, MBA, OCS, FAAOMPT | John Morris MPT, MBA, OCS, FAAOMPT | Bill Egan, PT, DPT, OCS, FAAOMPT

Course Information: Many clinical trials report significant improvements in osteoarthritis-related pain and function after total knee arthroplasty (TKA). Opioids are commonly prescribed for pain management of knee osteoarthritis, and also perioperative pain after surgery. The extent of persistent opioid use after TKA is unknown.  Because up to 20% of individuals have poor outcomes after TKA and prior opioid use is a risk factor for future opioid use, treatment effects from TKA clinical trials would be better understood by assessing opioid use data from trial participants. The purpose of this review was to determine the proportion of participants in TKA trials with opioid use prior to surgery and persistent use after surgery, and how well clinical trials capture and report these variables. A systematic review of the literature was conducted to assess the reporting of opioid use in TKA clinical trials. All opioid use was extracted, both prior and postoperatively. Long-term opioid use was determined using four different contemporary definitions, to increase the sensitivity of the assessment. This lecture will discuss the findings of this systematic review and a call for action to have opioid tracking as an outcome after total joint replacement.

Approved for 1 General Contact Hour

Register Today!